News

< Back to News

Cancer Immunotherapy ETF Rings Nasdaq Opening Bell

Oct. 31, 2016

Exchange Traded Concepts, Loncar Investments, and Cancer Research Institute rang the Nasdaq Open Bell to celebrate advances in cancer immunotherapy and the listing anniversary of the CNCR Immunotherapy ETF.

See more at Nasdaq.com >

Opinions expressed are those of the author or Funds and are subject to change, are not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

CNCR CRI Loncar


Sign up to receive the latest news about our ETFs and more.